Characteristics | ||
---|---|---|
Age (year), mean ± SD | 34.57 ± 10.8 | |
Age group, n (%) | 18–29 Years | 131 (35.1) |
30–39 Years | 131 (35.1) | |
40–49 Years | 71 (19.0) | |
>50 Years | 40 (10.7) | |
Sex, n (%) | Male | 140 (37.5) |
Female | 233 (62.5) | |
Opportunistic infections, n (%) | Yes | 97 (26.0) |
No | 276 (74.0) | |
WHO clinical stage, n (%) | Stage I/II | 226 (60.6) |
Stage III/IV | 147 (39.4) | |
CD4 count (Cells/mm3), median (IQR) | 182 (94–313) | |
CD4 count (Cells/mm3), n (%) | <200 | 206 (55.2) |
200–350 | 94 (25.2) | |
>350 | 73 (19.6) | |
Haemoglobin (Hgb), mean ± SD | 12.84 ± 2.12 | |
Serum Creatinine (SCr), mean ± SD | 0.94 ± 0.43 | |
eGFR, mean ± SD | 115.9 ± 43.45 |